SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096967
Filing Date
2024-08-14
Accepted
2024-08-14 16:00:22
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-20240630.htm   iXBRL 10-Q 1388184
2 EX-10.1 cue-ex10_1.htm EX-10.1 50673
3 EX-10.2 cue-ex10_2.htm EX-10.2 62980
4 EX-31.1 cue-ex31_1.htm EX-31.1 12956
5 EX-31.2 cue-ex31_2.htm EX-31.2 13079
6 EX-32.1 cue-ex32_1.htm EX-32.1 10413
7 GRAPHIC img77947453_0.jpg GRAPHIC 28234
8 GRAPHIC img77947453_1.jpg GRAPHIC 142670
9 GRAPHIC img77947453_2.jpg GRAPHIC 23159
10 GRAPHIC img77947453_3.jpg GRAPHIC 22277
11 GRAPHIC img77947453_4.jpg GRAPHIC 130090
12 GRAPHIC img77947453_5.jpg GRAPHIC 63904
13 GRAPHIC img77947453_6.jpg GRAPHIC 19274
14 GRAPHIC img77947453_7.jpg GRAPHIC 13798
15 GRAPHIC img77947453_8.jpg GRAPHIC 18083
16 GRAPHIC img77947453_9.jpg GRAPHIC 14857
  Complete submission text file 0000950170-24-096967.txt   7644336

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20240630.xsd EX-101.SCH 1132170
79 EXTRACTED XBRL INSTANCE DOCUMENT cue-20240630_htm.xml XML 906523
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 241207185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)